Back to Daily DR Market Summary

StreetAccount Summary - Asian Market Preview: Nikkei Futures +0.29%, Hang Seng Futures +0.10%, ASX SPI 200 +0.06%, S&P Futures (0.00%)

Dec 23 ,2024

The Asian Market Preview will not be published on 25-Dec. It will return on 26-Dec.

  • Synopsis:

    • Asian market set for quiet start to Tuesday trade. Japan and Hong Kong futures traded up slightly. ASX flat in initial trade. S&P 500 futures unchanged following tech-led advance on Monday (SOX up 3%). Australian and New Zealand yield curve bear steepening after Treasuries weakened overnight. FX markets steady with yen hovering near five-month low against dollar. Crude and gold remain rangebound. Bitcoin recovering after falling to one-month low.

    • South Korean consumer confidence fell by most since Mar-2020 this month amid martial law fallout that fueled market volatility. Survey also steep falls in outlook for economy and consumption. RBA minutes will be scrutinized for detail on central bank's policy bias after December policy statement signaled more neutral stance. October BOJ minutes also out after central bank left policy on hold that month with members seeing need to proceed with caution amid uncertainties.

    • Not much else on the radar ahead of Christmas. In other headlines, Honda and Nissan confirmed plans to sign M&A agreement by Jun-2025 with aim of integrating by Aug-2026. Biden administration confirmed probe into legacy chips made in China that could pave way for tariffs on imports. IMFs Article IV on Australia warned of downside risks and need for fiscal restraint to support disinflation.

  • Pre-open Company News:

    • 010130.KS -- Korea Zinc announces 10-for-1 stock split, effective 12-Feb

    • 034730.KS -- SK to sell 12.8M shares of subsidiary SK Specialty to Hahn & Co. for KRW2.701T

    • 9966.HK -- Alphamab Oncology initiated buy at Soochow Securities (timing uncertain)

    • 603517.CH -- Juewei Food terminates plans to list in Hong Kong

    • 1093.HK -- NMPA approves China trial of CSPC Pharmaceutical Group's SYH2062

    • 1109.HK -- China Resources Land appoints Xu Rong as president, effective today

    • 9660.HK -- Horizon Robotics initiated overweight at Western Securities (timing uncertain)

    • 9863.HK -- Zhejiang Leapmotor Technology initiated buy at SWS Research (timing uncertain)

    • 600958.CH -- Orient Securities president Lu Weiming to step down, effective today

    • 1318.HK -- Mao Geping Cosmetics initiated buy at Sinolink Securities (timing uncertain)

    • 002432.CH -- Andon Health initiated buy at Soochow Securities (timing uncertain)

    • 601179.CH -- China XD Electric initiated buy at Huatai Securities (timing uncertain)

    • 300487.CH -- Sunresin New Materials initiated buy at Changjiang Securities (timing uncertain)

    • 600547.CH -- Shandong Gold Mining initiated overweight at Western Securities (timing uncertain)

    • 002624.CH -- Perfect World to sell Chengfeng Studio assets to Savvy Games Group's Scopely for $34.5M (CNY251.8M)

  • On Deck:

    • China:

      • Economic:

        • 08:00 CST: Foreign Direct Investment Y/Y; consensus

    • Japan:

      • Earnings:

        • Takashimaya (8233.JP)

    • Australia:

      • Earnings:

        • St. Barbara (SBM.AU)

    • Singapore:

      • Earnings:

        • Keppel DC REIT (AJBU.SP), Yangzijiang Shipbuilding (Holdings) (BS6.SP), Raffles Medical Group (BSL.SP)

  • Market Data:

    • Gold (Feb 25): +$2.40 or +0.09% to $2630.60

    • WTI Crude (Feb 25): +$0.24 or +0.35% to $69.48

    • $-¥: +0.78 or +0.50% to 157.1900

    • $-KRW: +0.80 or +0.05% to 1447.1500

    • A$-$: (0.00) or (0.08%) to 0.6245

    • $-INR: +0.14 or +0.17% to 85.0917

    • $-CNY: +0.00 or +0.01% to 7.2973

  • If you would like to receive the Asian Market Preview daily, please search for Asia Pre-Market Updates in Alert Manager.

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE